羟胺 溶液

• 产品号: 438227
• CAS号: 7803-49-8
• 分子式: H3NO
• 分子量: 33.02992

产品别名

• 标题: Hydroxylamine solution
• IUPAC标准名: hydroxylamine
• IUPAC传统名: hydroxylamine
• 别名: HDA

产品登记号

• CAS号: 7803-49-8
• MDL号: MFCD00044522
• PubChem SID: 24867438
• EC号: 232-259-2

产品性质

• 浓度: 50 wt. % in H2O
• 线性分子式: NH2OH
• 沸点: >100 °C
• 密度: 1.078 g/mL at 25 °C
• 蒸汽压: 9 mmHg ( 40 °C)
• GHS警示词: Danger
• GHS危险声明: H290-H302 + H312-H315-H317-H318-H335-H351-H373-H400
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• 欧盟危险性物质标志: 环境危害性(Nature polluting) (N)
• 个人保护装置: Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
• GHS警示性声明: P261-P273-P280-P305 + P351 + P338
• RID/ADR: UN 3082 9/PG 3
• 危险公开号: 5-21/22-37/38-40-41-43-48/22-50
• RTECS编号: NC2975000
• 安全公开号: 26-36/37/39-46-61
• 联合国危险货物等级: 9
• 联合国危险货物编号: 3082
• 联合国危险货物包装类别(PG): 3
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Packaging
50, 250 mL in poly bottle
Application
Reactant for preparation of:
• Prodrug for cardiovascular agent Nω-hydroxy-L-arginine (NOHA, nitric oxide precursor)1
• Hydroxyaminoguanidines as anti-cancer agents2
• Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced phosphoenolpyruvate caboxykinase (PEPCK) transactivation3
• Carboxamide derivatives of ofloxacin with improved antimicrobial properties4
• Analogues of coumarin based TNF-α converting enzyme (TACE) inhibitors5
• HIV integrase inhibitors6

详细说明 (简体中文)

包装
50, 250 mL in poly bottle
Application
Reactant for preparation of:
• Prodrug for cardiovascular agent Nω-hydroxy-L-arginine (NOHA, nitric oxide precursor)1
• Hydroxyaminoguanidines as anti-cancer agents2
• Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced phosphoenolpyruvate caboxykinase (PEPCK) transactivation3
• Carboxamide derivatives of ofloxacin with improved antimicrobial properties4
• Analogues of coumarin based TNF-α converting enzyme (TACE) inhibitors5
• HIV integrase inhibitors6